SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012444
Filing Date
2022-05-09
Accepted
2022-05-09 08:02:55
Documents
84
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1294560
2 ex10-1.htm EX-10.1 20866
3 ex10-4.htm EX-10.4 60365
4 ex10-5.htm EX-10.5 52992
5 ex31-1.htm EX-31.1 17958
6 ex31-2.htm EX-31.2 18037
7 ex32-1.htm EX-32.1 6065
8 ex32-2.htm EX-32.2 6452
9 ex10-4_001.jpg GRAPHIC 14700
  Complete submission text file 0001493152-22-012444.txt   6119236

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE vbiv-20220331.xsd EX-101.SCH 48511
11 XBRL CALCULATION FILE vbiv-20220331_cal.xml EX-101.CAL 67621
12 XBRL DEFINITION FILE vbiv-20220331_def.xml EX-101.DEF 160768
13 XBRL LABEL FILE vbiv-20220331_lab.xml EX-101.LAB 361579
14 XBRL PRESENTATION FILE vbiv-20220331_pre.xml EX-101.PRE 278088
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 941881
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 22903312
SIC: 2834 Pharmaceutical Preparations